BCG Vaccine Market Anticipated to Grow at an Impressive Rate during the Period

BCG Vaccine Market Anticipated to Grow at an Impressive Rate during the Period
Press Release

As there is no current alternative to BCG vaccine, therefore there is an urgent need to improve the methods used for quality control of BCG. This is possible with the help of technological advancements in the field of genomics and proteomics, which can help in development of new methods for BCG testing. These advanced testing methods can ensure the safety, quality, and efficacy of BCG vaccine preparations.

BCG vaccine market size is estimated to hit $28,051 thousand by 2023 from $20,366 thousand in 2016, rising at a CAGR of 4.6% from 2017 to 2023. The Indian BCG vaccines market holds the highest share in the global BCG vaccines market.

 Download Report Sample @

The major companies profiled in the report include

  • Merck & Co. Inc.
  • Sanofi Pasteur
  • Japan BCG Laboratory
  • China National Biotec Group (a subsidiary of China National Pharmaceutical Group Corporation)
  • Serum Institute of India Pvt. Ltd.
  • InterVax Ltd.
  • GreenSignal Bio Pharma Limited (GSBPL)
  • Statens Serum Institut

Bacillus Calmette-Gurin (BCG) vaccine is the only vaccine currently available for prevention of tuberculosis (TB). One dose of BCG vaccine is recommended for healthy babies at birth in countries where tuberculosis is common.

The major factor that contributes to the market growth are increase in incidence rate of tuberculosis in developing nations, rise in R&D activities related to vaccines, and growth in government initiatives and focus on immunization programs globally. However, side reactions of BCG vaccines on patients and shortage of vaccine supply hinder the market growth. Moreover, untapped market opportunities in developing regions are expected to provide numerous opportunities for market growth.

The pediatrics segment is expected to maintain its dominant position during the analysis period, as the vaccine is administered to all the children at the time of birth. As BCG is recommended for only one dose; therefore, it is used rarely in the case of adults.

Key Findings of the BCG Vaccine Market:

  • The pediatrics segment accounted for more than three-fourths share of the global market in 2016.
  • China is expected to grow at a rapid CAGR of 6.2% from 2017 to 2023.
  • India accounted for one-sixth of the global market in 2016.
  • The adults segment is expected to grow at a CAGR of 3.6% from 2017 to 2023.

Get a purchase enquiry @

This post was originally published on Pharmaceutical Industry